Associated Papers
HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy.
Gan J et al.
Oncotargets and Therapy, 2021
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.
Fojo T et al.
Bmc Medical Genomics, 2020
33148256 (PubMed )
Supplement: 12920_2020_809_MOESM2_ESM.xlsx › Supplemental_Table_1__part_2_
Select a paper to view details